Skip to content

Scientist Jitendra Singh advocates for evidence-based knowledge on obesity and metabolic disorders

Dr. Singh attends the debut of the book "The Weight Loss Transformation: A Guide to Utilizing Weight Loss Medications," co-written by endocrinologist Dr. Ambrish Mithal and Shivam Vij.

Government official Dr. Jitendra Singh emphasizes the need for credible, scientific evidence...
Government official Dr. Jitendra Singh emphasizes the need for credible, scientific evidence regarding obesity and metabolic disorders

Scientist Jitendra Singh advocates for evidence-based knowledge on obesity and metabolic disorders

In the realm of healthcare and technology, several significant strides have been made recently.

Firstly, Zydus Therapeutics has announced positive topline results from the EPICS-III Phase 2(b)/3 Trial. This clinical research, conducted by the pharmaceutical company, is aimed at investigating a potential treatment for a specific condition.

In a separate development, Zydus Therapeutics has not disclosed any details about partnerships or collaborations. However, the positive results from the EPICS-III trial certainly indicate investor confidence in the company's research and development efforts.

Meanwhile, in the realm of women and child healthcare, Mahajan Imaging & Labs has partnered with Fortis La Femme. This collaboration is expected to enhance services and care in the women and child healthcare sector.

Moving on, the National Health Authority (NHA) organized the ABDM 2.0 southern region consultation meeting. The Indian Institute of Information Technology Hyderabad (IIITH) played host to this event, which focused on discussions and strategies related to digital health infrastructure in the region.

On a different note, SetPoint Medical has secured funding for its neuromodulation approaches for autoimmune conditions. This funding is a testament to the investor confidence in these innovative treatment methods. GlobalData, a data and analytics company, has issued a statement regarding this funding, but no further details about the partnership or the specific autoimmune conditions being targeted have been disclosed.

Lastly, an organisation called MTaI is advocating for the inclusion of medical technology products under the ERSO initiative. This move is aimed at ensuring proper consideration and regulation of these products, with the ultimate goal of improving integration and support for them within the healthcare system. However, more context about the ERSO initiative and MTaI is needed for a full understanding of their roles and objectives.

These developments underscore the ongoing efforts to advance healthcare and technology, with a focus on improving patient care, research, and digital infrastructure. As more information becomes available, we will continue to keep you updated on these exciting advancements.

Read also:

Latest